Search results for " renal disease"

showing 10 items of 46 documents

CAPD + hemoperfusion once a week in the management of children with end-stage renal disease

1983

With hemoperfusion there is a sharp decline in the solute concentration of the blood compartment, but immediately after HP the concentration of these substances rises to the original level (post-Hp rebound). It may be inferred that the result would be better and the rebound phenomenon less marked if hemoperfusion could be combined with a continuous dialysis system such as CAPD. The study was performed in 3 children of our CAPD programm. All patients were dialysed with 5 daily exchange each of one liter. The patients underwent at 2-hours hemoperfusion with a charcoal column (Gambro Adsorba 150 c) once a week. The data obtained with this form of treatment are indicative for a: significant in…

Malemedicine.medical_specialtymedicine.medical_treatment030232 urology & nephrologyBiomedical EngineeringUrologyMedicine (miscellaneous)Bioengineering030204 cardiovascular system & hematologyEnd stage renal diseasePeritoneal dialysisBiomaterials03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePeritoneal Dialysis Continuous AmbulatoryHumansMedicinePlatelet activationChildIntensive care medicineDialysisCreatininebusiness.industryLiterGeneral MedicineHemoperfusionUric AcidHemoperfusionchemistryCreatinineKidney Failure ChronicUric acidFemalebusinessPeritoneal Dialysis
researchProduct

Changes in serum fetuin-A and inflammatory markers levels in end-stage renal disease (ESRD): effect of a single session haemodialysis.

2007

Background: The aim of the present study was to evaluate the effect of a single haemodialysis (HD) session on serum fetuin-A levels, considered a negative acute phase response marker; moreover, we evaluated the behaviour of fibrinogen and high sensitivity C-reactive protein (hsCRP) as acute phase response and chronic/subclinical inflammation markers, respectively, after a single HD session. Methods: Serum fetuin-A, albumin, hsCRP and fibrinogen were measured in 72 patients before and after a single HD session. Results: After a single HD session, we observed a significant increase in fibrinogen levels, while fetuin-A levels decreased (p<0.05). Also, hsCRP levels were significantly increased.…

Malemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryInflammationFibrinogenEnd stage renal diseaseRenal DialysisInternal medicinemedicineHumansAgedbusiness.industryBiochemistry (medical)Acute-phase proteinAlbuminGeneral MedicineMiddle Agedmedicine.diseaseFetuinEndocrinologyKidney Failure ChronicFemaleHemodialysisalpha-Fetoproteinsmedicine.symptomInflammation MediatorsbusinessKidney diseasemedicine.drugClinical chemistry and laboratory medicine
researchProduct

Incidence of chronic pain in patients with end-stage renal disease on dialysis

2005

Malemedicine.medical_specialtymedicine.medical_treatmentMEDLINEPainend-stage renal disease dialysisEnd stage renal diseaseText miningRenal DialysisInternal medicinemedicineHumansIn patientGeneral NursingDialysisAgedbusiness.industryIncidenceIncidence (epidemiology)Chronic painMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicineChronic diseaseChronic DiseaseKidney Failure ChronicFemaleNeurology (clinical)businesschronic pain
researchProduct

[Penile Flexiflate® Surgitek prosthesis explant and simultaneous three-component hydraulic Titan® Alpha 1 prosthesis implantation, with double incisi…

2010

Introduction and Objectives We treated a 45 years old patient, suffering from diabetes mellitus since childhood, with retinal, neurovascular and kidney complications. In 1988, for erectile dysfunction (ED) resistant to medical injective treatment, the patient underwent ligation of the dorsal vein of the penis without any result. In 1989 a Flexiflate® hydraulic prosthesis was implanted with resolution of ED. In 2005 the patient underwent simultaneous kidney and pancreas transplant with a trans-laparotomic approach for end stage renal disease and diabetes mellitus. In 2009, because of the Flexiflate® Surgitek malfunction, the patient underwent explantation of the Flexiflate® prosthesis and si…

Malemedicine.medical_specialtymedicine.medical_treatmentProsthesis ImplantationProsthesisEnd stage renal diseaseProsthesis ImplantationDiabetic NeuropathiesErectile DysfunctionLaparotomymedicineHumansDiabetic NephropathiesLigationDevice Removalbusiness.industryPenile prosthesisGeneral MedicineEquipment DesignMiddle AgedNeurovascular bundleKidney TransplantationSurgerymedicine.anatomical_structureDiabetes Mellitus Type 1Patient SatisfactionKidney Failure ChronicImplantPancreas TransplantationPenile ProsthesisbusinessPenisDiabetic AngiopathiesPenisUrologia
researchProduct

Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.

2009

Background Nephrogenic systemic fibrosis (NSF) affects some patients on dialysis after gadolinium contrast agent–enhanced magnetic resonance imaging. It is characterized by progressive skin fibrosis of the extremities, sometimes including the trunk and internal organs. Methods The clinical course of 10 patients with biopsy-proven NSF was analyzed retrospectively with regard to gadolinium exposition, disease onset, and progression of NSF with special emphasis on physical mobility and impact of different therapeutic approaches. Results Despite physiotherapy and different additional therapeutic approaches (eg, immunosuppression, ultraviolet A-1 phototherapy, or extracorporal photopheresis) all…

Nephrogenic Fibrosing DermopathyAdultmedicine.medical_specialtymedicine.medical_treatmentBiopsyGadoliniumDermatologyHydronephrosisNephrectomyEnd stage renal diseaseNephrogenic Fibrosing DermopathyPhotopheresisFibrosisRenal DialysismedicineHumansKidney transplantationDialysisbusiness.industrymedicine.diseaseMagnetic Resonance ImagingSurgeryNephrogenic systemic fibrosisDisease ProgressionFemalebusinessKidney diseaseJournal of the American Academy of Dermatology
researchProduct

A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of h…

2012

Background: Calciphylaxis is a potentially fatal complication of persistent secondary hyperparathyroidism; its cause is still not clear. Unfortunately there is no close relation in severity of clinical picture, serological and pathological alteration. For this reason the prognosis is difficult to establish. Administration of sodium thiosulphate may reduce the precipitation of calcium crystals and improve the general clinical conditions before surgical parathyroidectomy, which seems the only therapeutic approach able to reduce the mortality risk in these patients. Methods and Results: A 60 year old female patient suffering from End Renal Stage Disease, on haemodialysis from 2001 due to the o…

ParathyroidectomyGraft Rejectionmedicine.medical_specialtymedicine.medical_treatmentCalciphylaxiSettore MED/08 - Anatomia PatologicaGeneral Biochemistry Genetics and Molecular BiologyEnd stage renal diseaseFatal OutcomeSecondary hyperparathyroidism; Calciphylaxis; Kidney transplant; ParathyroidectomymedicineHumansKidney transplantDialysisParathyroidectomySettore MED/14 - NefrologiaCalciphylaxisHyperparathyroidismbusiness.industryCalciphylaxisMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSecondary hyperparathyroidismSettore MED/18 - Chirurgia GeneraleHemolytic-Uremic SyndromeKidney Failure ChronicSecondary hyperparathyroidismFemaleHyperparathyroidism SecondaryComplicationbusinessBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct

Sistemic calciphylaxis and thrombotic microangiopathy in a kidney transplant patient: Two mixing fatal syndromes?

2012

Abstract Abnormalities in calcium and phosphorus metabolism are common and metabolic bone diseases develop often in patients with chronic renal failure (CRF). Effective clinical management includes measures to control phosphorus retention and prevent hyperphosphataemia, to maintain serum calcium concentrations within the normal range and to prevent excess parathyroid hormone (PTH) secretion by the judicious use of vitamin D sterols. Certain of these interventions, however, appear to increase the risk of soft tissue and vascular calcification in patients with End Stage Renal Disease (ESRD), so current therapeutic approaches are thus being re-evaluated in an effort to limit these risks. Patie…

Parathyroidectomymedicine.medical_specialtyPathologyCalciplhylaxisThrombotic microangiopathymedicine.medical_treatmentHemolitic Huremic SyndromeSettore MED/08 - Anatomia PatologicaGastroenterologyPhosphorus metabolismEnd stage renal diseaseInternal medicineSettore MED/35 - Malattie Cutanee E VenereemedicineHumansKidney transplantationSettore MED/14 - NefrologiaCalciphylaxisThrombotic Microangiopathiesbusiness.industryCalciphylaxisEnd Stage Renal Disease; Hemolitic Huremic Syndrome; CalciplhylaxisGeneral MedicineModels Theoreticalmedicine.diseaseKidney TransplantationSettore MED/18 - Chirurgia GeneraleSecondary hyperparathyroidismEnd Stage Renal DiseasebusinessCalcificationMedical Hypotheses
researchProduct

Calidad de la farmacoterapia y seguridad de los pacientes en hemodiálisis tratados con estimulantes eritropoyéticos

2008

Objective: To assess an interdisciplinary programme for the improvement of pharmacotherapy quality and patient safety in patients with chronic renal disease who are treated with erythropoiesis-stimulating agents. Method: Observational, longitudinal study. Retrospective analysis (period A) and prospective analysis (period B) following implementation of the programme for haemoglobin values and monthly erythropoiesis- stimulating agent dosage. The proportion of patients with haemoglobin values within the target range (10-5-12.5 g/dl) and those with values above the safety limit (≥ 12.5g/dl) were compared every four months and the average percentage of time with haemoglobin values within the ta…

PharmacologyLongitudinal studymedicine.medical_specialtybusiness.industryHaemoglobin levelsChronic renal diseaseTarget rangePharmacotherapyInternal medicineRetrospective analysisMedicineIn patientEvery Four MonthsbusinessFarmacia Hospitalaria
researchProduct

La qualità della vita in soggetti in età evolutiva affetti da patologie renali croniche

2005

Atra. Renai pathologies bave an hard impact on ili children's life style, psychic and physical development. Inthelastyears, evenif medicai cures allowed these children to live longer and to bave a better quality of life, today both their families and themselves bave to face a lot of difficulties due to thè kind of pathology. These cbildren show behaviour troubles, bad sociability, aggressiveness, poorschool performance, anxiety and depression, and then thè subjects with chronic renai failure show a retard in neurological and cognitive development In this study we evatuated thè impact that thè chronic renai illness has on children and adolescente' quality life. Methods. Por this study, we ba…

Quality of life Chronic renal diseases ChildSettore MED/39 - Neuropsichiatria Infantile
researchProduct

An Elevated Neutrophil-Lymphocyte Ratio Increases the Risk of Cardiovascular Events and of Renal Function Decline in Hypertensive Patients with CKD

2021

Introduction: Many epidemiological studies have shown that low-grade chronic inflammation, estimated through the neutrophil-lymphocyte ratio (NLR), is linked to traditional and non-traditional cardiovascular (CV) risk factors. Aim: The aim of our study was to investigate the potential prognostic role of NLR regarding the progression of chronic kidney disease (CKD) and the development of CV events in a cohort of renal and hypertensive patients. Methods: In this retrospective observational study, 403 patients consecutively attending our Nephrology and Hypertension clinics were included. At the baseline observation and control visits in all patients, in addition to the clinical-anamnestic eval…

Settore MED/14 - NefrologiaSubclinical inflammationSettore MED/09 - Medicina Internaneutrophil/lymphocyte ratioprogression of renal diseasecardiovascular events.
researchProduct